Corex
15.06.2020

EMA ISSUES GUIDELINES FOR REMOTE GOOD CLINICAL PRACTICE INSPECTIONS

coronavirus
EMA ISSUES GUIDELINES FOR REMOTE GOOD CLINICAL PRACTICE INSPECTIONS
On 10 June 2020, the Europeans Medicines Agency (EMA) issued guidance on how remote good clinical practice inspections (GCP) should be carried out during the coronavirus pandemic. The EMA stressed the importance of inspections to its assessment of marketing authorization applications. However, it recognizes that on-site inspections may not be possible due to the ongoing pandemic due to travel restrictions and risks to staff health.


The EMA therefore recommends that inspection teams, with agreement from the Committee for Medicinal Products for Human Use (CHMP), should make the decision on the appropriateness of using remote inspection on a case-by-case basis while also taking into account existing procedures for GCP inspections and considering the potential limitations of using a remote process.


It notes that these remote processes should not be viewed as a replacement for on-site GCP inspections but are a necessary consideration in the current circumstances. The EMA further notes that while standard procedures apply in the case of remote inspection, preparation for them will be more complex and require an assessment of whether the necessary technical requirements can be met to provide remote access. It advises on early engagement with sponsors and sites. The guidance cautions: “Remote inspections require a more customised preparation by the inspectee and the inspection team as compared to on-site inspections.”


The guidance covers all phases of remote GCP inspections, with a particular focus on the more challenging aspects, such inspection initiation, feasibility assessment and preparation.
Read more here (EMA website).

Back to the list

Industry insights

Ethics committees

Ethics committee supervision is a vital part of all clinical trials.

Ivan Polyakov appointed Director of D...

At COREX Logistics we are keeping pace with these developments investing in new technologies to make the supply chain more transparent, transportation more efficient and most importantly getting vital medicines to patients safely and on time. We’re also investing in our people who will drive digital transformation.

COREX ACADEMY: A NEW CHAPTER

COREX Logistics is delighted to announce a “new chapter in clinical trial logistics” with...

CONTACT US

We’re here to help.
Email us at info@corex-depot.com or use our feedback form to send us your question.

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy. Read More.